Anakinra utilization in refractory pediatric CAR T-cell associated toxicitiesCaroline Diorio, Nirali N. Shah, Anant Vatsayan et al.|Blood Advances|2022Cited by 56
Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemiaGeorge Mo, Nirali N. Shah, Hao‐Wei Wang et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 31
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent ToxicitiesKevin O. McNerney, Jenna Rossoff, Emily M. Hsieh et al.|Transplantation and Cellular Therapy|2023Cited by 20
Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon‐Kiu Yan, Jiyang Yu, Jose Condori et al.|Science Advances|2023Cited by 9
Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell MalignanciesJennifer L. McGuire, Juliane Gust, Soniya Pinto et al.|Neurology|2025Cited by 8